A single dose, open-label, crossover study evaluating pharmacokinetics and bioequivalence in fasted state of heat-stressed and non-heat-stressed Dapagliflozin tablets in healthy volunteers.

Trial Profile

A single dose, open-label, crossover study evaluating pharmacokinetics and bioequivalence in fasted state of heat-stressed and non-heat-stressed Dapagliflozin tablets in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Sep 2016

At a glance

  • Drugs Dapagliflozin (Primary)
  • Indications Diabetes mellitus
  • Focus Pharmacokinetics
  • Most Recent Events

    • 26 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top